(

(

Healthcare

Healthcare

)

)

Novel topical treatments for ophthalmic diseases

Novel topical treatments for ophthalmic diseases

Novel topical treatments for ophthalmic diseases

STATUS:

Current

Oculis is a global biopharmaceutical company dedicated to improving eye care and preserving sight. Their clinical-stage pipeline includes innovative product candidates for eye diseases with high unmet needs. Oculis aims to provide life-changing eye treatment worldwide.

Oculis is a global biopharmaceutical company dedicated to improving eye care and preserving sight. Their clinical-stage pipeline includes innovative product candidates for eye diseases with high unmet needs. Oculis aims to provide life-changing eye treatment worldwide.

(Entrepreneurs)

(Entrepreneurs)

Riad Sherif, CEO

Rebecca Weil, CCO

Sylvia Cheung, CFO

(VI Partners)

(VI Partners)

(Fund)

(Fund)

Vi-21

Portfolio News